GADADERM Frozen Ice Advance Pain Relief

Manufacturer
GADAL Laboratories, Inc
Effective date
2016-11-18
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 22:48:02

Label at a glance#

ProductGADADERM Frozen Ice Advance Pain Relief
Active ingredientMETHYL SALICYLATE, MENTHOL, CAMPHOR (NATURAL)
Label structure6 sections

Label contents#

Full prescribing information#

ACTIVE INGREDIENTS

OTC - ACTIVE INGREDIENT SECTION

Active IngredientsPurpose
Methyl Salicylate 10%Topical Analgesic
Menthol 10%Topical Analgesic
Camphor 3.1%Topical Analgesic

INACTIVE INGREDIENT

INACTIVE INGREDIENT SECTION

Carbopol, Cetearyl Alcohol, Disodium EDTA, FD&C Blue #1, Glycerin, Hydroxypropyl Methylcellulose, Menthylparaben, Propylene Glycol, Propylparaben, Polysorbate 20, Purified Water, Stearic Acid, Sodium Hydroxide.

WARNINGS

WARNINGS SECTION

For the external use only. When using this product use as directed.

  • Do not bandage tightly or use with heating pad. Avoid contact with eyes and mucous membranes.
  • Do not apply to wounds or damaged, broken, or irritated skin.
  • If severe burning sensation occurs, discontinue use immediately.
  • Do not expose the area treated with product to heat or direct sunlight.
  • Stop use and ask a doctor if conditions worsen, redness is present, irritation develops.

If swallowed, get medical help or contact a Poison Control Center right away. IF MEDICINE COMES IN CONTACT WITH HANDS, WASH WITH SOAP AND WATER.

DOSAGE & ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Adults and children 12 years of age and older; apply generously to affected area massage into painful area until thoroughly absorbed into skin. Repeat as necessary but not more than 3 to 4 times daily.

PURPOSE

OTC - PURPOSE SECTION

For temporary relief of minor aches and pains of muscles and joints associated with simple backache, arthritis, strains, bruises, sprains.

GADADERM Frozen Ice Advance Pain Relief

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Label Image
Label Image

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1438765camphor 3.1 % / menthol 10 % / methyl salicylate 10 % Topical GelPSN2
1438765camphor 0.031 MG/MG / menthol 0.1 MG/MG / methyl salicylate 0.1 MG/MG Topical GelSCD2
1438765camphor 3.1 % / methyl salicylate 10 % / menthol 10 % Topical GelSY2

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
53113-362-092020-01-31C16284748780-19d75b9d0-34bd-f424-e053-dadaa90a57ce7bf21905-975a-472d-a2d6-a9c1408e7f95

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
53113-362-09GADADERM Frozen Ice Advance Pain Relief99 g in 1 TUBEGEL992

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
53113-362GADADERM FROZEN ICE ADVANCE PAIN RELIEF (SALICYLIC ACID MENTHOL CAMPHOR (NATURAL)) GEL [GADAL LABORATORIES, INC]2Legacy NDC, 1 package rows20161119_7bf21905-975a-472d-a2d6-a9c1408e7f95.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 19 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
53113-36253113-362-09

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 16 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
f65d52ae-8348-4691-b432-7ca05fad5fd37bf21905-975a-472d-a2d6-a9c1408e7f952016-11-18WarningsExact identifier
spl id: f65d52ae-8348-4691-b432-7ca05fad5fd3
spl set id: 7bf21905-975a-472d-a2d6-a9c1408e7f95

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.